Rituximab

【Product name】Rituxan

[English common name]Rituximab

[Chinese common name]Rituximab

[English name]

[Chinese other name]

[Indications] This product is suitable for: recurrent or drug-resistant follicular central lymphoma (international work classification B, C and D subtype B cell non-Hodgkin's lymphoma)Treatment. Previously untreated CD20-positive stage III-IV follicular non-Hodgkin's lymphoma, patients should be treated with standard CVP chemotherapy (Cyclophosphamide,VincristineAnd prednisone) 8 cycles of combined treatment. CD20-positive diffuse large B-cell non-Hodgkin's lymphoma (DLBCL) should be treated in combination with standard CHOP chemotherapy (cyclophosphamide, doxorubicin, vincristine, prednisone) for 8 cycles.

[Usage and Dosage] Usage and Usage Instructions Under the sterile conditions, the required dose of rituximab is taken and placed in a sterile non-pyrogenic infusion bag containing 0.9% saline or 5% dextrose solution. The concentration of rituximab was 1 mg/ml. Gently invert the injection bag to mix the solution and avoid foaming. As this product does not contain antimicrobial preservatives or bacteriostatic preparations, aseptic technique must be checked. The injection should be observed for particles or discoloration before intravenous use. Rituximab is diluted and administered intravenously through a dedicated infusion tube for the treatment of patients in ambulatory bed. The treatment of rituximab should be performed in a ward with complete resuscitation equipment and under the direct supervision of an experienced oncologist or hematologist. Monitor patients with respiratory symptoms or hypotension for at least 24 hours.

[Storage] Sealed.

[Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.